Trials / Terminated
TerminatedNCT01921569
Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis
Micronized Dehydrated Human Amniotic Membrane (dHACM) Suspension in the Treatment of Lateral Epicondylitis.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- MiMedx Group, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether micronized dehydrated human amniotic membrane (dHACM) suspension is more effective in reducing inflammation than conservative measures alone when used to treat acute/early lateral epicondylitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standard of Care Therapy | Rest, ice, compression, elevation (RICE), NSAID or salicylate medication for pain, Physical Therapy and stretching exercises, Reduction in impact activities, to include an arm sling. |
| OTHER | dHACM Injection | Injection into affected area with micronized dHACM suspended with total volume of 1 cc normal saline. |
| OTHER | Normal Saline Injection | Injection into affected area with 1.0 cc normal saline solution instead of active agent. |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2013-08-13
- Last updated
- 2015-09-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01921569. Inclusion in this directory is not an endorsement.